| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT07069699 | Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With… | Burkitt Lymphoma | Recruiting |
| NCT07147231 | Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination… | Metastatic Colorectal Adenocarcinoma | Recruiting |
| Phase 1 | |||
| NCT06606990 | Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With… | Metastatic Malignant Solid Neoplasm | Recruiting |
| NCT04890613 | Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous… | Advanced Solid Tumor | Recruiting |
| NCT07137416 | Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and… | Anatomic Stage III Breast Cancer AJCC v8 | Recruiting |